Marina Go has been appointed Chair of Ovarian Cancer Australia, replacing Paula Benson who steps down after eight years in the role.
Jane Hill, the organisation’s CEO, said Benson’s contribution and passion has driven significant change for those affected by ovarian cancer.
Benson is a survivor of ovarian cancer herself, having joined the board four years after she was diagnosed.
“I feel very fortunate that my cancer was caught early and I have been able to use my skills and experience to make a contribution to Ovarian Cancer Australia,” she said.
Benson led the organisation’s National Action Plan for Ovarian Cancer Research and 25/25 vision to reduce the incidence of ovarian cancer and improve the survival rates by 25 per cent by 2025.
Go joined the board earlier this year, and currently has a range of board roles including as Chair of the Wests Tigers NRL Club, Chair of Office Brands, a Non- Executive Director of Energy Australia, Autosports Group, 7-Eleven and The Walkley Foundation, Chair of the Advisory Board of the Centre for Media Transition at the University of Technology Sydney. She is also the founding publisher of Women’s Agenda and author of the business book for women, Break Through: 20 Success Strategies for Female Leaders.
Go also has a personal connection to ovarian cancer, given her husband carries the BRCA1 gene mutation, which is the likely reason behind why many of the women on her husband’s side of the family, including Ovarian Cancer Australia founder Lynda Gibson, developed ovarian cancer.
“I’m absolutely committed to Ovarian Cancer Australia’s vision to save lives and ensure no woman with ovarian cancer walks alone as well as our ambitious goal to reduce the incidence of ovarian cancer and improve the disease’s survival rate by 25 per cent by 2025,” she said.